Because of the angioarchitectural diversity of Spetzler-Martin (SM) Grade III arteriovenous malformations (AVMs), the management of these lesions is incompletely defined. The aims of this multicenter, retrospective cohort study were to evaluate the outcomes after stereotactic radiosurgery (SRS) for SM Grade III AVMs and to determine the factors predicting these outcomes.
The authors analyzed and pooled data from patients with SM Grade III AVMs treated with SRS at 8 institutions participating in the International Gamma Knife Research Foundation. Patients with these AVMs and a minimum follow-up length of 12 months were included in the study cohort. An optimal outcome was defined as AVM obliteration, no post-SRS hemorrhage, and no permanently symptomatic radiation-induced changes (RICs). Data were analyzed by univariate and multivariate regression analyses.
The SM Grade III AVM cohort comprised 891 patients with a mean age of 34 years at the time of SRS. The mean nidus volume, radiosurgical margin dose, and follow-up length were 4.5 cm3, 20 Gy, and 89 months, respectively. The actuarial obliteration rates at 5 and 10 years were 63% and 78%, respectively. The annual postradiosurgery hemorrhage rate was 1.2%. Symptomatic and permanent RICs were observed in 11% and 4% of the patients, respectively. Optimal outcome was achieved in 56% of the patients and was significantly more frequent in cases of unruptured AVMs (OR 2.3, p < 0.001). The lack of a previous hemorrhage (p = 0.037), absence of previous AVM embolization (p = 0.002), smaller nidus volume (p = 0.014), absence of AVM-associated arterial aneurysms (p = 0.023), and higher margin dose (p < 0.001) were statistically significant independent predictors of optimal outcome in a multivariate analysis.
Stereotactic radiosurgery provided better outcomes for patients with small, unruptured SM Grade III AVMs than for large or ruptured SM Grade III nidi. A prospective trial or registry that facilitates a comparison of SRS with conservative AVM management might further clarify the authors' observations for these often high-risk AVMs.
ABBREVIATIONSARUBA = A Randomized Trial of Unruptured Brain AVMs; AVM = arteriovenous malformation; EBRT = external-beam radiation therapy; RBAS = radiosurgery-based AVM score; RIC = radiation-induced change; SAIVM = Scottish Audit of Intracranial Vascular Malformations; SM = Spetzler-Martin; SRS = stereotactic radiosurgery; VRAS = Virginia Radiosurgery AVM Scale.
INCLUDE WHEN CITING Published online April 15, 2016; DOI: 10.3171/2016.1.JNS152564.Correspondence Jason Sheehan, Department of Neurosurgery, University of Virginia Health System, PO Box 800212, Charlottesville, VA 22908. email: firstname.lastname@example.org.
AblaAARutledgeWCSeymourZAGuoDKimHGuptaN: A treatment paradigm for high-grade brain arteriovenous malformations: volume-staged radiosurgical downgrading followed by microsurgical resection. J Neurosurg122:419–4322015
Al-Shahi SalmanR, WhitePM, CounsellCE, du PlessisJ, van BeijnumJ, JosephsonCB, : Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. 311:1661–1669, 201410.1001/jama.2014.3200)| false
DingDLiuKC: Predictive capability of the Spetzler-Martin versus supplementary grading scale for microsurgical outcomes of cerebellar arteriovenous malformations. J Cerebrovasc Endovasc Neurosurg15:307–3102013
DingD, LiuKC: Predictive capability of the Spetzler-Martin versus supplementary grading scale for microsurgical outcomes of cerebellar arteriovenous malformations. 15:307–310, 201310.7461/jcen.2013.15.4.30724729957)| false
DingD, XuZ, YenCP, StarkeRM, SheehanJP: Radiosurgery for cerebral arteriovenous malformations in elderly patients: effect of advanced age on outcomes after intervention. 84:795–804, 20152599779710.1016/j.wneu.2015.05.012)| false
DingD, YenCP, XuZ, StarkeRM, SheehanJP: Radiosurgery for primary motor and sensory cortex arteriovenous malformations: outcomes and the effect of eloquent location. 73:816–824, 824:201310.1227/NEU.000000000000010623867301)| false
KanoHKondziolkaDFlickingerJCYangHCFlanneryTJNiranjanA: Stereotactic radiosurgery for arteriovenous malformations, Part 4: management of basal ganglia and thalamus arteriovenous malformations. J Neurosurg116:33–432012
KanoHLunsfordLDFlickingerJCYangHCFlanneryTJAwanNR: Stereotactic radiosurgery for arteriovenous malformations, Part 1: management of Spetzler-Martin Grade I and II arteriovenous malformations. J Neurosurg116:11–202012
KanoH, LunsfordLD, FlickingerJC, YangHC, FlanneryTJ, AwanNR, : Stereotactic radiosurgery for arteriovenous malformations, Part 1: management of Spetzler-Martin Grade I and II arteriovenous malformations. 116:11–20, 201210.3171/2011.9.JNS10174022077452)| false
KimHAblaAANelsonJMcCullochCEBerviniDMorganMK: Validation of the supplemented Spetzler-Martin grading system for brain arteriovenous malformations in a multicenter cohort of 1009 surgical patients. Neurosurgery76:25–332015
KimH, AblaAA, NelsonJ, McCullochCE, BerviniD, MorganMK, : Validation of the supplemented Spetzler-Martin grading system for brain arteriovenous malformations in a multicenter cohort of 1009 surgical patients. 76:25–33, 201510.1227/NEU.0000000000000556)| false
KoltzMTPolifkaAJSaltosASlawsonRGKwokYAldrichEF: Long-term outcome of Gamma Knife stereotactic radiosurgery for arteriovenous malformations graded by the Spetzler-Martin classification. J Neurosurg118:74–832013
LeeCCReardonMABallBZChenCJYenCPXuZ: The predictive value of magnetic resonance imaging in evaluating intracranial arteriovenous malformation obliteration after stereotactic radiosurgery. J Neurosurg123:136–1442015
LeeCC, ReardonMA, BallBZ, ChenCJ, YenCP, XuZ, : The predictive value of magnetic resonance imaging in evaluating intracranial arteriovenous malformation obliteration after stereotactic radiosurgery. 123:136–144, 20152583992310.3171/2014.10.JNS141565)| false
MohrJPParidesMKStapfCMoqueteEMoyCSOverbeyJR: Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet383:614–6212014
MohrJP, ParidesMK, StapfC, MoqueteE, MoyCS, OverbeyJR, : Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. 383:614–621, 20142426810510.1016/S0140-6736(13)62302-8)| false
OndraSL, TrouppH, GeorgeED, SchwabK: The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. 73:387–391, 199010.3171/jns.1990.73.3.03872384776)| false
PollockBEKondziolkaDFlickingerJCPatelAKBissonetteDJLunsfordLD: Magnetic resonance imaging: an accurate method to evaluate arteriovenous malformations after stereotactic radiosurgery. J Neurosurg85:1044–10491996
PollockBE, KondziolkaD, FlickingerJC, PatelAK, BissonetteDJ, LunsfordLD: Magnetic resonance imaging: an accurate method to evaluate arteriovenous malformations after stereotactic radiosurgery. 85:1044–1049, 199610.3171/jns.19126.96.36.19948929493)| false
StarkeRM, YenCP, ChenCJ, DingD, MohilaCA, JensenME, : An updated assessment of the risk of radiation-induced neoplasia after radiosurgery of arteriovenous malformations. 82:395–401, 20142340335410.1016/j.wneu.2013.02.008)| false
StarkeRM, YenCP, DingD, SheehanJP: A practical grading scale for predicting outcome after radiosurgery for arteriovenous malformations: analysis of 1012 treated patients. 119:981–987, 20132382982010.3171/2013.5.JNS1311)| false
WegnerREOysulKPollockBESirinSKondziolkaDNiranjanA: A modified radiosurgery-based arteriovenous malformation grading scale and its correlation with outcomes. Int J Radiat Oncol Biol Phys79:1147–11502011